Cargando…
Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling
BACKGROUND: Non-small-cell lung cancer (NSCLC) is the major leading cause of cancer-related death around the world. The resistance to chemotherapy limits the effects of clinical treatment. The aim of this study was to identify novel mechanisms involved in NSCLC chemoresistance. MATERIALS AND METHODS...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163007/ https://www.ncbi.nlm.nih.gov/pubmed/30288060 http://dx.doi.org/10.2147/OTT.S175606 |